Literature DB >> 16557204

PET/CT for atherosclerotic plaque imaging.

S Ben-Haim1, O Israel.   

Abstract

Atherosclerosis is one of the leading causes of morbidity and mortality in the world. Rupture of atherosclerotic plaques and thrombi formation are the primary mechanisms of myocardial infarction or cerebrovascular accident. Angiography is considered to represent the gold standard technique for imaging of the arterial lumen. However, in recent years it has been realized that the primary determinant of the atherosclerotic plaque stability is the composition of the plaque and other imaging modalities have been suggested. The purpose of this review is to briefly summarize the knowledge accumulated to present date regarding the potential role of fluodeoxyglucose imaging in the assessment of atherosclerosis and to compare this modality to additional available imaging approaches for the detection of vulnerable plaques.

Entities:  

Mesh:

Year:  2006        PMID: 16557204

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  7 in total

Review 1.  Imaging atherosclerosis in the vulnerable patient.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01       Impact factor: 9.236

2.  Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?

Authors:  E E van der Wall; J D Schuijf; J W Jukema; J J Bax; A van der Laarse
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-05       Impact factor: 2.357

3.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.

Authors:  Mehmet Balın; Ahmet Celik; M Ali Kobat
Journal:  Clin Res Cardiol       Date:  2011-11-25       Impact factor: 5.460

Review 4.  Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI Part I and II.

Authors:  Bernard C M te Boekhorst; Maarten J Cramer; Gerard Pasterkamp; Cees J A van Echteld; Pieter A F M Doevendans
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-29       Impact factor: 2.357

5.  Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).

Authors:  Monica Bucci; Carina Mari Aparici; Randy Hawkins; Steve Bacharach; Carole Schrek; Suchun Cheng; Elizabeth Tong; Sandeep Arora; Eugenio Parati; Max Wintermark
Journal:  J Neuroimaging       Date:  2012-08-28       Impact factor: 2.486

6.  99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.

Authors:  Seigo Ishino; Yuji Kuge; Nozomi Takai; Nagara Tamaki; H William Strauss; Francis G Blankenberg; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-11       Impact factor: 10.057

7.  Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT.

Authors:  Quan-ming Zhao; Xin Zhao; Ting-ting Feng; Ming-duo Zhang; Xu-cui Zhuang; Xue-cheng Zhao; Li-qin Li; De-peng Li; Yu Liu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.